Home  |  Contact

UniProtKB/Swiss-Prot P53355: Variant p.Ser1346Asn

Death-associated protein kinase 1
Gene: DAPK1
Variant information

Variant position:  1346
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Serine (S) to Asparagine (N) at position 1346 (S1346N, p.Ser1346Asn).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to medium size and polar (N)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  1346
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1430
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.



Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 1430 Death-associated protein kinase 1
Domain 1312 – 1396 Death
Alternative sequence 784 – 1430 Missing. In isoform 2.

Literature citations

Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death.
Deiss L.P.; Feinstein E.; Berissi H.; Cohen O.; Kimchi A.;
Genes Dev. 9:15-30(1995)

The full-ORF clone resource of the German cDNA consortium.
Bechtel S.; Rosenfelder H.; Duda A.; Schmidt C.P.; Ernst U.; Wellenreuther R.; Mehrle A.; Schuster C.; Bahr A.; Bloecker H.; Heubner D.; Hoerlein A.; Michel G.; Wedler H.; Koehrer K.; Ottenwaelder B.; Poustka A.; Wiemann S.; Schupp I.;
BMC Genomics 8:399-399(2007)

NIEHS SNPs program;

DNA sequence and analysis of human chromosome 9.
Humphray S.J.; Oliver K.; Hunt A.R.; Plumb R.W.; Loveland J.E.; Howe K.L.; Andrews T.D.; Searle S.; Hunt S.E.; Scott C.E.; Jones M.C.; Ainscough R.; Almeida J.P.; Ambrose K.D.; Ashwell R.I.S.; Babbage A.K.; Babbage S.; Bagguley C.L.; Bailey J.; Banerjee R.; Barker D.J.; Barlow K.F.; Bates K.; Beasley H.; Beasley O.; Bird C.P.; Bray-Allen S.; Brown A.J.; Brown J.Y.; Burford D.; Burrill W.; Burton J.; Carder C.; Carter N.P.; Chapman J.C.; Chen Y.; Clarke G.; Clark S.Y.; Clee C.M.; Clegg S.; Collier R.E.; Corby N.; Crosier M.; Cummings A.T.; Davies J.; Dhami P.; Dunn M.; Dutta I.; Dyer L.W.; Earthrowl M.E.; Faulkner L.; Fleming C.J.; Frankish A.; Frankland J.A.; French L.; Fricker D.G.; Garner P.; Garnett J.; Ghori J.; Gilbert J.G.R.; Glison C.; Grafham D.V.; Gribble S.; Griffiths C.; Griffiths-Jones S.; Grocock R.; Guy J.; Hall R.E.; Hammond S.; Harley J.L.; Harrison E.S.I.; Hart E.A.; Heath P.D.; Henderson C.D.; Hopkins B.L.; Howard P.J.; Howden P.J.; Huckle E.; Johnson C.; Johnson D.; Joy A.A.; Kay M.; Keenan S.; Kershaw J.K.; Kimberley A.M.; King A.; Knights A.; Laird G.K.; Langford C.; Lawlor S.; Leongamornlert D.A.; Leversha M.; Lloyd C.; Lloyd D.M.; Lovell J.; Martin S.; Mashreghi-Mohammadi M.; Matthews L.; McLaren S.; McLay K.E.; McMurray A.; Milne S.; Nickerson T.; Nisbett J.; Nordsiek G.; Pearce A.V.; Peck A.I.; Porter K.M.; Pandian R.; Pelan S.; Phillimore B.; Povey S.; Ramsey Y.; Rand V.; Scharfe M.; Sehra H.K.; Shownkeen R.; Sims S.K.; Skuce C.D.; Smith M.; Steward C.A.; Swarbreck D.; Sycamore N.; Tester J.; Thorpe A.; Tracey A.; Tromans A.; Thomas D.W.; Wall M.; Wallis J.M.; West A.P.; Whitehead S.L.; Willey D.L.; Williams S.A.; Wilming L.; Wray P.W.; Young L.; Ashurst J.L.; Coulson A.; Blocker H.; Durbin R.M.; Sulston J.E.; Hubbard T.; Jackson M.J.; Bentley D.R.; Beck S.; Rogers J.; Dunham I.;
Nature 429:369-374(2004)

Patterns of somatic mutation in human cancer genomes.
Greenman C.; Stephens P.; Smith R.; Dalgliesh G.L.; Hunter C.; Bignell G.; Davies H.; Teague J.; Butler A.; Stevens C.; Edkins S.; O'Meara S.; Vastrik I.; Schmidt E.E.; Avis T.; Barthorpe S.; Bhamra G.; Buck G.; Choudhury B.; Clements J.; Cole J.; Dicks E.; Forbes S.; Gray K.; Halliday K.; Harrison R.; Hills K.; Hinton J.; Jenkinson A.; Jones D.; Menzies A.; Mironenko T.; Perry J.; Raine K.; Richardson D.; Shepherd R.; Small A.; Tofts C.; Varian J.; Webb T.; West S.; Widaa S.; Yates A.; Cahill D.P.; Louis D.N.; Goldstraw P.; Nicholson A.G.; Brasseur F.; Looijenga L.; Weber B.L.; Chiew Y.-E.; DeFazio A.; Greaves M.F.; Green A.R.; Campbell P.; Birney E.; Easton D.F.; Chenevix-Trench G.; Tan M.-H.; Khoo S.K.; Teh B.T.; Yuen S.T.; Leung S.Y.; Wooster R.; Futreal P.A.; Stratton M.R.;
Nature 446:153-158(2007)
Cited for: VARIANTS [LARGE SCALE ANALYSIS] ILE-416; SER-461; ALA-519; TYR-540; THR-941; TRP-977; ASN-978; CYS-993; GLU-994; GLN-1005; TYR-1007; PRO-1008; CYS-1010; ALA-1018; ILE-1272; ASN-1346 AND VAL-1405;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.